TCTMD

Spectranetics Announces FDA Submission of Bridge(TM) Occlusion Balloon for Lead Extraction Procedures

COLORADO SPRINGS, Colo., The Spectranetics Corporation today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission of the Bridge Occlusion Balloon. Building on the ...
BioWorld

Spectranetics obtains clearance of bridge occlusion balloon

The Spectranetics Corp. said it received clearance of its bridge occlusion balloon for temporary vessel occlusion in cardiac lead extraction procedures. The Colorado Springs, Colorado-based company ...
Healio

FDA classifies bridge occlusion balloon catheter recall as class I

Please provide your email address to receive an email when new articles are posted on . A recent recall of a bridge occlusion catheter has been classified as class I, the most serious kind, due to the ...
FierceBiotech

Spectranetics Corporation (SPNC) Initiates Voluntary Recall of Specific Lots of Thrombus Extraction Catheter

COLORADO SPRINGS, Colo., Jul 01, 2010 (BUSINESS WIRE) -- Spectranetics Corporation /quotes/comstock/15*!spnc/quotes/nls/spnc (SPNC 5.19, +0.03, +0.58%) today ...
Seeking Alpha

Spectranetics Corp Q2 2010 Earnings Call Transcript

Spectranetics reached a number of important milestones during the second quarter. Our highlights include, total revenue for the quarter reached $30 million driven by Lead Management revenue growth of ...
BioWorld

Device targets SVC tears: Spectranetics eyes 'bridge' to successful lead extraction with FDA submission

The U.S. FDA’s final guidance for clinical decision support (CDS) systems may be the subject of two citizen’s petitions requesting the agency scrap the guidance ...
Business Wire

Spectranetics Strengthens Peripheral Vascular Portfolio with a Partnership to Distribute the TAPAS™ Catheter

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq:SPNC) today announced an agreement with ThermopeutiX, Inc. to commercialize the TAPAS catheter, a therapeutic infusion ...